FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:561-566 August 22, 2002 Number 8 Next

Abstract PDF PDA Full Text PowerPoint Slide Set Perspective by MacGillivray, T. E. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Minimally invasive bypass surgery and coronary-artery stenting are both accepted treatments for isolated stenosis of the proximal left anterior descending coronary artery. We compared the clinical outcomes after these two procedures.

Methods A total of 220 symptomatic patients with high-grade lesions in the proximal left anterior descending coronary artery were randomly assigned to treatment — 110 to surgery and 110 to stenting. The combined clinical end point was freedom from major adverse cardiac events, such as death from cardiac causes, myocardial infarction, and the need for repeated revascularization of the target lesion within six months.

Results A major adverse cardiac event occurred in 31 percent of patients after stenting, as compared with 15 percent in the surgery group (P=0.02). The difference was predominantly due to a higher rate of repeated revascularization of the target vessel for restenosis after stenting (29 percent vs. 8 percent, P=0.003). The combined rates of death and myocardial infarction did not differ significantly between groups (3 percent in the stenting group and 6 percent in the surgery group, P=0.50). Adverse events occurred more frequently after surgery. The percentage of patients free from angina after six months was 79 percent in the surgery group, as compared with 62 percent in the stenting group (P=0.03).

Conclusions In patients with isolated high-grade lesions of the proximal left anterior descending artery, both minimally invasive bypass surgery and stenting are effective. Stenting yields excellent short-term results with fewer periprocedural adverse events, but surgery is superior with regard to the need for repeated intervention in the target vessel and freedom from angina at six months of follow-up.

Methods

Study Patients

Patients with isolated high-grade lesions (stenosis of 75 percent of the luminal diameter) in the proximal left anterior descending artery were included in the study. The lesion had to be confined to the segment between the origin of the left circumflex coronary artery and the first major septal branch. Patients were excluded if they had acute coronary syndromes requiring immediate intervention, additional clinically significant coronary lesions or valvular heart disease requiring treatment, or stenosis of the first diagonal branch or stenosis extending over a major diagonal branch or if they had previously undergone interventional or surgical treatment for coronary artery disease. Patients with total occlusion and patients with an intramyocardial course of the left anterior descending artery were also excluded, since minimally invasive surgery requires full visualization of the target vessel. The cardiac surgeon and the cardiologist had to agree on the eligibility of each patient before randomization. The study was approved by the local ethics committee. Written informed consent was obtained from all patients. Balanced randomization was performed by means of the drawing of sealed, unlabeled, unordered envelopes from an urn.

Angiographic Analysis

Angiography was performed in multiple projections after intracoronary application of nitroglycerin. Quantitative computed analysis was performed by an operator who was unaware of the patient's identity, using a validated image-processing algorithm (CMS, version 3.0, Medis). The diameters of the normal segments proximal and distal to the treated area were averaged to determine the reference diameter. Minimal luminal diameter and percentage of stenosis were calculated. In the surgery group, the reduction in luminal diameter was confined to the anastomotic site; therefore, no distal reference diameter of the internal thoracic artery could be obtained. Restenosis was defined as stenosis of more than 50 percent of the luminal diameter.

Stenting Procedure

Stenting was performed according to standard clinical practice. The femoral approach was used, with a 6-French or 8-French guiding catheter. All patients began to receive 350 mg of aspirin per day and either 500 mg of ticlopidine per day or 300 mg of clopidogrel per day on the day before the procedure. Administration of ticlopidine or clopidogrel continued for a minimum of four weeks, and aspirin was given indefinitely. A bolus of 10,000 U of heparin was given at the beginning of the intervention. Selection of the balloon size was based on visual assessment of the target vessel. A balloon-to-vessel ratio of between 1.1 and 1.2 was recommended. Primary stenting without predilation was used whenever feasible. The choice of stent was left to the operator.

Minimally Invasive Bypass Surgery

The technique of minimally invasive direct coronary-artery bypass surgery has been described in detail elsewhere.¹⁵ In brief, a limited left anterolateral thoracotomy was performed through the fourth intercostal space. The internal thoracic artery was harvested under direct vision. After the administration of heparin (100 U per kilogram of body weight), the internal thoracic artery was divided distally. Local immobilization of the anastomotic site was achieved with mechanical stabilizers. The anastomosis was performed with the use of one running 8-0 polypropylene suture on the beating heart. Protamine was applied to neutralize 80 percent of the dose of heparin. Wounds were closed in a standard fashion.

Follow-up

All patients were monitored for at least 24 hours. Creatine kinase activity was measured and 12-lead electrocardiography was performed immediately after the procedure and 6, 12, and 18 hours later. Patients assigned to surgery underwent angiography before discharge. Myocardial infarction was diagnosed either if the ratio of serum creatine kinase MB isoenzyme (CK-MB) to total cardiac enzyme exceeded 0.1 or if the CK-MB value was three times the upper limit of normal. In addition, standard electrocardiographic criteria were applied.

Six-month follow-up included a complete clinical workup with a symptom-limited exercise stress test and coronary angiography. In case of recurrence of angina, a positive stress test, or both, a repeated intervention was performed.

Statistical Analysis

The primary composite end point was defined as freedom from major adverse cardiovascular events, which included death from cardiac causes, myocardial infarction, and the need for repeated revascularization of the target lesion within six months. Secondary end points included each individual component of the composite end point, the clinical status as assessed according to the Canadian Cardiovascular Society (CCS) classification,¹⁶ and the need for antianginal drugs at six months of follow-up. In addition, periprocedural adverse events were documented.

The sample size was chosen in order to achieve 95 percent statistical power with a type I error of 5 percent with the use of a two-sided Fisher's exact test. In order to allow for losses to follow-up, we recruited 10 additional patients for each group. On the basis of previous reports, it was assumed that 30 percent of the patients treated by stenting and 9 percent of those treated by surgery would reach the combined primary end point.

All analyses were conducted according to the intention-to-treat principle. All events occurring after randomization were included in the analysis. Patients who were lost to follow-up were excluded from further analysis. In addition, patients who did not undergo repeated angiography were excluded from the calculation of the overall rate of restenosis (Figure 1). Data for the categorical variables are expressed as the number and the percentage of patients. For continuous variables, data are reported as estimated means ±SD, and values were compared by unpaired Student's t-tests after testing for normal distribution. Fisher's exact test or a chi-square test was used for categorical variables with nominal scales, and the Wilcoxon or Mann–Whitney rank-sum test was used for those with ordinal scales. Rates of events were compared by the calculation of unadjusted relative risks with 95 percent confidence intervals. All statistical tests were two-tailed. A P value of less than 0.05 was considered to indicate statistical significance. There were no interim analyses.

View larger version (24K): [in this window] [in a new window]   Figure 1. Numbers of Patients Included in the Analyses.

 
Results

Study Patients

Between June 1997 and June 2001, 220 consecutive patients were randomly assigned to treatment — 110 to stenting and 110 to minimally invasive surgery. There were no significant differences between the groups with respect to demographic characteristics or base-line variables (Table 1). The mean (±SD) interval between randomization and treatment was 2±3 days (range, 0 to 23) among patients assigned to stenting and 14±46 days (range, 0 to 106) among patients assigned to surgery (P<0.001). All patients received the assigned treatment, and there were no adverse events in patients awaiting surgery or stenting.

View this table: [in this window] [in a new window]   Table 1. Base-Line Characteristics of the Patients.

 
Clinical Outcome

            Stenting

Stenting was successful in all patients, and there were no complications. The mean percentage of stenosis was significantly reduced (Table 2). An average of 1.2±0.4 stents were implanted at a mean stent-dilation pressure of 13.3±1.7 atm. The mean length of a stent was 15.1±4.3 mm. GFX stents (Medtronic) were used in 64 patients, Pura-Vario (Devon Medical) in 10, Inflow (Inflow Dynamics) in 9, Micro II (Arterial Vascular Engineering) in 7, MAC (AMG) in 10, MAC Carbon (AMG) in 4, and Sito (Jomed) in 6.

View this table: [in this window] [in a new window]   Table 2. Results of Quantitative Coronary Angiography.

 
After stenting, a retroperitoneal hematoma developed in two patients; the hematomas were managed conservatively. One patient had an acute myocardial infarction due to early stent thrombosis, which was treated with balloon angioplasty and abciximab. In another patient who stopped taking aspirin and ticlopidine, subacute stent thrombosis developed two weeks after stent implantation; the occlusion was recanalized by balloon angioplasty. In one patient, a ruptured plaque in the left circumflex coronary artery caused an acute myocardial infarction two months after hospital discharge. Two patients died from strokes three months after the intervention.

            Minimally Invasive Bypass Surgery

Minimally invasive surgery was successfully performed in 95 percent of the patients in the surgery group. In five patients, conversion to a full sternotomy was necessary because of an intramyocardial segment of the left anterior descending coronary artery (in three patients), an injured internal thoracic artery (in one patient), and severe pleural adhesions (in one patient). These patients had an otherwise uneventful course.

Three patients underwent reoperation during the hospitalization for the first operation because of anastomotic stenosis or occlusion; two of these patients had a perioperative myocardial infarction during the first operation. In two patients, the anastomosis was erroneously performed on the first diagonal branch; in one of these patients, stenting of the native vessel had to be performed; the second patient had adequate perfusion of the territory of the left anterior descending artery. Two other patients had perioperative myocardial infarction despite grafts that were shown to be patent on angiography. One patient had an ischemic stroke five days after the procedure. Chest-wall hernia requiring surgical repair occurred in two patients during the six-months of follow-up.

One patient died during a maximal bicycle exercise test 10 days after surgery. Autopsy revealed rupture of the graft, which was probably caused by mechanical resuscitation. Another patient died at a rehabilitation center 15 days after surgery; since this death was not witnessed and no autopsy was performed, the cause of death could not be ascertained. During follow-up, one patient had an acute myocardial infarction due to a new lesion of the left circumflex artery, which was treated by stenting. The mean duration of hospitalization after surgery was 9±4 days (range, 4 to 36), as compared with 2±3 days after stenting (range, 1 to 28) (P<0.001).

Follow-up Results

Follow-up was complete for all patients except for two patients in the surgery group. Two asymptomatic patients refused repeated cardiac catheterization after stenting, as did eight patients after surgery (Figure 1).

After surgery, the mean CCS angina class improved from 2.6±0.9 to 0.3±0.7 (P<0.001), and 79 percent of patients were free of angina. After stenting, the angina class improved from 2.6±0.9 to 0.7±1.0 (P<0.001 for the comparison with base line; P=0.02 for the comparison with the surgery group), and 62 percent were free of angina (P=0.03 for the comparison with the surgery group). Six percent of patients in the surgery group required antianginal drug therapy, as compared with 19 percent in the stenting group (P=0.006). Physical-work capacity, however, was similar in the two groups (a workload of 120±37 W in the stenting group and 127±34 W in the surgery group, P=0.15).

At six months of follow-up, in-stent restenosis was detected in 35 patients, and 29 of these underwent repeated revascularization (by balloon angioplasty in 25 patients and surgery in 4 patients) for recurrent angina, a positive stress test, or both. Subgroup analysis showed a restenosis rate of 18 percent for type A lesions, 26 percent for type B lesions, and 56 percent for type C lesions (P=0.008). The classification of stenoses is based on a variety of morphologic criteria that assess the degree of complexity of the lesion.¹⁷ In the surgery group, 18 patients had a stenosis of more than 50 percent of the luminal diameter at the anastomotic region or in the bypass graft; 5 of those patients required interventional treatment, and the other 13 patients, who were asymptomatic, were treated conservatively, since the restenoses at the anastomotic site were in the range of 50 to 60 percent of the luminal diameter.

There were significantly more repeated interventions after stenting than after surgery (Table 3). However, death from cardiac causes and myocardial infarction, alone or together, were uncommon, and the rates did not differ significantly between groups.

View this table: [in this window] [in a new window]   Table 3. Major Adverse Cardiac Events during Six Months of Follow-up.

 
Discussion

Stenting has become the preferred treatment for isolated lesions of the left anterior descending coronary artery. The combination of balloon angioplasty, stenting, and antiplatelet treatment has reduced the rate of acute dissections and restenoses even among lesions with complex morphology. Interventional approaches have therefore found widespread application, whereas primary surgical treatment is recommended in only a few cases, despite the lack of randomized studies comparing the two approaches.

Location of the lesion in the proximal left anterior descending artery has been defined as an independent risk factor for restenosis after balloon dilation,¹⁸ as well as after stenting. Despite implementation of state-of-the-art techniques in our study, the restenosis rate remained essentially unchanged from previous studies, in which rates ranged from 33 percent to 44 percent.^10,19,20 In one study, a restenosis rate of only 19 percent was reported, but the investigators had excluded patients with well-known risk factors for restenosis, such as long lesions (>15 mm in length), small vessels (<3 mm in diameter), and a high mean percentage of stenosis.¹² In our study, stent implantation might have been suboptimal in some patients, since the final percentage of stenosis was more than 10 percent; this fact might be explained by the visual rather than quantitative assessment during the procedure. Another factor influencing the restenosis rate might be the use of stents with a strut thickness of more than 100 µm, which is also an independent risk factor for restenosis.²¹

Our results reflect the advantages and disadvantages of stenting of the proximal left anterior descending artery. Stenting is a safe intervention even in lesions with complex morphologic features. The rate of periprocedural adverse events is low, with stent thrombosis in 2 of 110 patients. However, only 2 percent of our patients received additional glycoprotein IIb/IIIa inhibitors, which is a potential limitation of the study. The incidence of early occlusions at the target site might have been reduced by the more frequent use of these platelet inhibitors, which have been shown to reduce the rate of periprocedural events, particularly among high-risk patients.^22,23 Our study confirms the predictive value of lesion morphology for the development of subsequent restenosis.²⁴ A restenosis rate of 56 percent was found among type C lesions, as compared with a rate of 18 percent among type A lesions. In contrast, in the surgery group, the risk of subsequent restenosis was independent of the type of lesion.

The major factors contributing to restenosis — elastic recoil and vessel-wall remodeling — are addressed by stenting. However, given that drug-eluting stents and intravascular radiation have not yet been approved for general use, there is currently no effective therapy for the prevention of neointimal proliferation.^25,26

Previous studies have demonstrated two major clinical outcomes favoring conventional coronary bypass surgery (with a sternotomy and cardiopulmonary bypass) over balloon dilation without stenting for the treatment of isolated lesions in the proximal left anterior descending artery: more complete relief of angina and a reduced need for repeated revascularization.^5,6 Despite these benefits, many patients prefer the less invasive catheter-based approach to conventional coronary bypass surgery.

The minimally invasive surgical approach minimizes surgical trauma by limiting the access to the heart and avoiding cardiopulmonary bypass. Medium-term patency rates similar to those achieved with conventional bypass grafting have been reported.²⁷ A recent study demonstrated a survival rate of 98 percent and a rate of repeated revascularization of less than 2 percent.¹⁵ The limited thoracotomy preserves sternal integrity and allows for a more rapid return to daily activities. More important, the avoidance of cardiopulmonary bypass reduces the immune response, preserves blood components, and improves postoperative neurocognitive function as compared with conventional cardiac surgery.^28,29 However, the limited access makes the procedure more challenging technically and may impair the quality of the anastomosis,^14,30 which is reflected in our study by a 3 percent rate of early reoperation for acute graft failure, two cases in which the anastomotic site was erroneously selected, and a 5 percent rate of conversion to full sternotomy.

After six months, all bypass grafts were patent, but irregularities at the anastomotic site were demonstrated by angiography in 18 percent of cases. This rate of irregularities can be partially attributed to the fact that, in contrast to other studies, our study used quantitative coronary angiography that is more sensitive than qualitative assessment in detecting restenosis.^14,31 However, repeated revascularization was necessary in only 5 percent of the patients, since most of the stenoses were in the range of 50 to 60 percent of luminal diameter. The limited degree of restenosis is also reflected by the more complete relief of anginal symptoms in the surgery group than in the stenting group. In studies comparing balloon angioplasty with bypass surgery, such differences were attenuated during later follow-up because of additional revascularization procedures.^6,9

Minimally invasive surgery is still a relatively new technique. Therefore, future developments and improved patient selection may further reduce periprocedural morbidity and the rate of early reinterventions. Because of the single-center design of this study, only experienced surgeons and interventional cardiologists participated in the trial. Finally, longer follow-up will be needed to address the long-term efficacy and costs of either stenting or surgery, since the efficacy of any therapy will be increasingly weighed against its costs.

Both stenting and minimally invasive bypass surgery are safe and effective treatment options for high-grade lesions in the proximal left anterior descending artery. Although stenting is the only truly minimally invasive therapy associated with fewer periprocedural events than surgery and can be considered the first-line option for lesions without complex morphologic features, surgery provides excellent outcome irrespective of the morphology of the lesion. Our study demonstrates that decisions about how to treat an isolated lesion in the proximal left anterior descending artery require an interdisciplinary approach. Patients should be informed about the alternative treatment options and about the rates of success and of periprocedural events among patients with lesions morphologically similar to theirs.

We are indebted to Carola Dönath and Kathrin Luderer for performing the quantitative angiographic analysis and to Dr. Goetz Gelbrich, biometrician at the Coordination Center for Clinical Trials, Leipzig, Germany, for his assistance with statistical analysis.

Source Information

From the Department of Cardiac Surgery (A.D., V.F., F.W.M.) and the Department of Internal Medicine and Cardiology (H.T., R.H., N.S., P.S., K.W.D., G.S.), University of Leipzig Heart Center, Leipzig, Germany.

Address reprint requests to Dr. Schuler at the Department of Internal Medicine and Cardiology, University of Leipzig Heart Center, Strümpellstr. 39, 04289 Leipzig, Germany, or at schug{at}medizin.uni-leipzig.de.

References

1. Varnauskas E, European Coronary Surgery Study Group. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1988;319:332-337. [Abstract]
2. Klein LW, Weintraub WS, Agarwal JB, et al. Prognostic significance of severe narrowing of the proximal portion of the left anterior descending coronary artery. Am J Cardiol 1986;58:42-46. [CrossRef][Web of Science][Medline]
3. Hueb WA, Bellotti G, de Oliveira SA, et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995;26:1600-1605. [Abstract]
4. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-16. [Abstract]
5. Goy JJ, Eeckhout E, Burnand B, et al. Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis. Lancet 1994;343:1449-1453. [CrossRef][Web of Science][Medline]
6. Goy JJ, Eeckhout E, Moret C, et al. Five-year outcome in patients with isolated proximal left anterior descending coronary artery stenosis treated by angioplasty or left internal mammary artery grafting: a prospective trial. Circulation 1999;99:3255-3259. [Free Full Text]
7. The Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Five-year clinical and functional outcome comparing bypass surgery and angioplasty with multivessel coronary disease: a multicenter randomized trial. JAMA 1997;277:715-721. [Free Full Text]
8. Henderson RA, Pocock SJ, Sharp SJ, et al. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Lancet 1998;352:1419-1425. [CrossRef][Web of Science][Medline]
9. Pocock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-1189. [CrossRef][Web of Science][Medline]
10. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501. [Free Full Text]
11. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495. [Free Full Text]
12. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffrè PA. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 1997;336:817-822. [Free Full Text]
13. Calafiore AM, Giammarco GD, Teodori G, et al. Left anterior descending coronary artery grafting via left anterior small thoracotomy without cardiopulmonary bypass. Ann Thorac Surg 1996;61:1658-1663. [Free Full Text]
14. Calafiore AM, Di Giammarco G, Teodori G, et al. Midterm results after minimally invasive coronary surgery (LAST operation). J Thorac Cardiovasc Surg 1998;115:763-771. [Free Full Text]
15. Diegeler A, Falk V, Matin M, et al. Minimally invasive coronary artery bypass grafting without cardiopulmonary bypass: early experience and follow-up. Ann Thorac Surg 1998;66:1022-1025. [Free Full Text]
16. Campeau L. Grading of angina pectoris. Circulation 1976;54:522-523. [Web of Science][Medline]
17. Ellis SG, Vandormael MG, Crowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation 1990;82:1193-1202. [Free Full Text]
18. Frierson JH, Dimas AP, Whitlow PL, et al. Angioplasty of the proximal left anterior descending coronary artery: initial success and long-term follow-up. J Am Coll Cardiol 1992;19:745-751. [Abstract]
19. Carrozza JP Jr, Kuntz RE, Levine MJ, et al. Angiographic and clinical outcome of intracoronary stenting: immediate and long-term results from a large single-center experience. J Am Coll Cardiol 1992;20:328-337. [Abstract]
20. Kastrati A, Schomig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997;30:1428-1436. [Abstract]
21. Kastrati A, Mehilli J, Dirschinger J, et al. Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) trial. Circulation 2001;103:2816-2821. [Free Full Text]
22. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-1696. [Free Full Text]
23. ESPRIT Investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet 2000;356:2037-2044. [Erratum, Lancet 2001;357:1370.] [CrossRef][Web of Science][Medline]
24. Kastrati A, Schomig A, Elezi S, et al. Prognostic value of the modified American College of Cardiology/American Heart Association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement. Circulation 1999;100:1285-1290. [Free Full Text]
25. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001;103:192-195. [Free Full Text]
26. Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-1703. [Free Full Text]
27. Mack MJ, Magovern JA, Acuff TA, et al. Results of graft patency by immediate angiography in minimally invasive coronary artery surgery. Ann Thorac Surg 1999;68:383-389. [Free Full Text]
28. Diegeler A, Hirsch R, Schneider F, et al. Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass surgery. Ann Thorac Surg 2000;69:1162-1166. [Free Full Text]
29. Diegeler A, Doll N, Rauch T, et al. Humoral immune response during coronary artery bypass grafting: a comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass. Circulation 2000;102:Suppl III:III-95. 
30. Calafiore AM, Teodori G, Di Giammarco G, et al. Minimally invasive coronary artery bypass grafting on a beating heart. Ann Thorac Surg 1997;63:Suppl:S72-S75. [CrossRef][Web of Science][Medline]
31. Gill IS, Higginson LA, Maharajh GS, Keon WJ. Early and follow-up angiography in minimally invasive coronary bypass without mechanical stabilization. Ann Thorac Surg 2000;69:56-60. [Free Full Text]

Abstract PDF PDA Full Text PowerPoint Slide Set Perspective by MacGillivray, T. E. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Related Letters:

Minimally Invasive Bypass Surgery
LoGerfo F. W., Drenth D. J., Veeger N. J.G.M., Boonstra P. W., D'Ancona G., Karamanoukian H., Dragu R. E., Wood W. C., Thiele H., Mohr F. W., Schuler G., MacGillivray T. E., Vlahakes G. J.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:2165-2168, Dec 26, 2002. Correspondence

This article has been cited by other articles:

• Thiele, H., Neumann-Schniedewind, P., Jacobs, S., Boudriot, E., Walther, T., Mohr, F.-W., Schuler, G., Falk, V. (2009). Randomized Comparison of Minimally Invasive Direct Coronary Artery Bypass Surgery Versus Sirolimus-Eluting Stenting in Isolated Proximal Left Anterior Descending Coronary Artery Stenosis. J Am Coll Cardiol 53: 2324-2331 [Abstract] [Full Text]  
• Kofidis, T., Gerd Paeschke, H., Lichtenberg, A., Emmert, M., Woitek, F., Didilis, V., Haverich, A., Klima, U. (2009). Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin. ICVTS 8: 49-53 [Abstract] [Full Text]  
• Kapoor, J. R., Gienger, A. L., Ardehali, R., Varghese, R., Perez, M. V., Sundaram, V., McDonald, K. M., Owens, D. K., Hlatky, M. A., Bravata, D. M. (2008). Isolated Disease of the Proximal Left Anterior Descending Artery: Comparing the Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Surgery. J Am Coll Cardiol Intv 1: 483-491 [Abstract] [Full Text]  
• Kiaii, B., McClure, R. S., Stewart, P., Rayman, R., Swinamer, S. A., Suematsu, Y., Fox, S., Higgins, J., Albion, C., Kostuk, W. J., Almond, D., Sridhar, K., Teefy, P., Jablonsky, G., Diamantouros, P., Dobkowski, W. B., Jones, P., Bainbridge, D., Iglesias, I., Murkin, J., Cheng, D., Novick, R. J. (2008). Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up. J. Thorac. Cardiovasc. Surg. 136: 702-708 [Abstract] [Full Text]  
• Shuhaiber, J., Reston, J. (2008). Time to Intervention During Cardiac Interventions. Are We Forgetting a Confounder?. Asian Cardiovasc. Thorac. Ann. 16: 1-3 [Full Text]  
• Kon, Z. N., Brown, E. N., Tran, R., Joshi, A., Reicher, B., Grant, M. C., Kallam, S., Burris, N., Connerney, I., Zimrin, D., Poston, R. S. (2008). Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass.. J. Thorac. Cardiovasc. Surg. 135: 367-375 [Abstract] [Full Text]  
• Falk, V., Mohr, F. W. (2008). Minimally Invasive Myocardial Revascularization. Card Surg Adult 3: 697-710 [Full Text]  
• Bravata, D. M., Gienger, A. L., McDonald, K. M., Sundaram, V., Perez, M. V., Varghese, R., Kapoor, J. R., Ardehali, R., Owens, D. K., Hlatky, M. A. (2007). Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery. ANN INTERN MED 147: 703-716 [Abstract] [Full Text]  
• Navia, J. L, Roselli, E. E, Atik, F. A, Gonzalez-Stawinski, G. V, Smedira, N. G (2007). Orthotopic Heart Transplantation through Minimally Invasive Approach. Asian Cardiovasc. Thorac. Ann. 15: 446-448 [Abstract] [Full Text]  
• de Canniere, D., Wimmer-Greinecker, G., Cichon, R., Gulielmos, V., Van Praet, F., Seshadri-Kreaden, U., Falk, V. (2007). Feasibility, safety, and efficacy of totally endoscopic coronary artery bypass grafting: Multicenter European experience. J. Thorac. Cardiovasc. Surg. 134: 710-716 [Abstract] [Full Text]  
• Jaffery, Z., Kowalski, M., Weaver, W. D., Khanal, S. (2007). A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery. Eur. J. Cardiothorac. Surg. 31: 691-697 [Abstract] [Full Text]  
• Bainbridge, D., Cheng, D., Martin, J., Novick, R., The Evidence-based Peri-operative Clinical Outcome, (2007). Does off-pump or minimally invasive coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with percutaneous coronary intervention? A meta-analysis of randomized trials. J. Thorac. Cardiovasc. Surg. 133: 623-631 [Abstract] [Full Text]  
• Holzhey, D. M., Jacobs, S., Mochalski, M., Walther, T., Thiele, H., Mohr, F. W., Falk, V. (2007). Seven-Year Follow-up After Minimally Invasive Direct Coronary Artery Bypass: Experience With More Than 1300 Patients. Ann. Thorac. Surg. 83: 108-114 [Abstract] [Full Text]  
• Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W. (2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease). Circulation 114: 2850-2870 [Full Text]  
• Ben-Gal, Y., Mohr, R., Braunstein, R., Finkelstein, A., Hansson, N., Hendler, A., Moshkovitz, Y., Uretzky, G. (2006). Revascularization of Left Anterior Descending Artery With Drug-Eluting Stents: Comparison With Minimally Invasive Direct Coronary Artery Bypass Surgery. Ann. Thorac. Surg. 82: 2067-2071 [Abstract] [Full Text]  
• Barner, H. B. (2006). Status of percutaneous coronary intervention and coronary artery bypass.. Eur. J. Cardiothorac. Surg. 30: 419-424 [Abstract] [Full Text]  
• Martens, T. P., Argenziano, M., Oz, M. C. (2006). New Technology for Surgical Coronary Revascularization. Circulation 114: 606-614 [Full Text]  
• Katz, M. R., Van Praet, F., de Canniere, D., Murphy, D., Siwek, L., Seshadri-Kreaden, U., Friedrich, G., Bonatti, J. (2006). Integrated Coronary Revascularization: Percutaneous Coronary Intervention Plus Robotic Totally Endoscopic Coronary Artery Bypass. Circulation 114: I-473-I-476 [Abstract] [Full Text]  
• Vassiliades, T. A. Jr, Douglas, J. S., Morris, D. C., Block, P. C., Ghazzal, Z., Rab, S. T., Cates, C. U. (2006). Integrated coronary revascularization with drug-eluting stents: Immediate and seven-month outcome. J. Thorac. Cardiovasc. Surg. 131: 956-962 [Abstract] [Full Text]  
• Boodhwani, M., Rubens, F. D., Sellke, F. W., Mesana, T. G., Ruel, M. (2006). Mortality and myocardial infarction following surgical versus percutaneous revascularization of isolated left anterior descending artery disease: a meta-analysis. Eur. J. Cardiothorac. Surg. 29: 65-70 [Abstract] [Full Text]  
• Budde, R. P.J., Bakker, P. F. A., Meijer, R., Borst, C., Grundeman, P. F. (2006). Ultrasound Mini-Transducer with Malleable Handle for Coronary Artery Surgery. Ann. Thorac. Surg. 81: 322-326 [Abstract] [Full Text]  
• Thiele, H., Oettel, S., Jacobs, S., Hambrecht, R., Sick, P., Gummert, J. F., Mohr, F. W., Schuler, G., Falk, V. (2005). Comparison of Bare-Metal Stenting With Minimally Invasive Bypass Surgery for Stenosis of the Left Anterior Descending Coronary Artery: A 5-Year Follow-Up. Circulation 112: 3445-3450 [Abstract] [Full Text]  
• Loisance, D. Y., Nakashima, K., Kirsch, M. (2005). Computer-assisted coronary surgery: lessons from an initial experience. ICVTS 4: 398-401 [Abstract] [Full Text]  
• Zimarino, M., Calafiore, A. M., De Caterina, R. (2005). Complete myocardial revascularization: between myth and reality. Eur Heart J 26: 1824-1830 [Abstract] [Full Text]  
• Fernandez-Aviles, F. (2005). Introduction: Diagnostic and interventional procedures for coronary artery disease: implications for selection of contrast media. Eur Heart J Suppl 7: G1-G3 [Full Text]  
• Brinker, J. A., Davidson, C. J., Laskey, W. (2005). Preventing in-hospital cardiac and renal complications in high-risk PCI patients. Eur Heart J Suppl 7: G13-G24 [Abstract] [Full Text]  
• Dangas, G., Ellis, S. G., Shlofmitz, R., Katz, S., Fish, D., Martin, S., Mehran, R., Russell, M. E., Stone, G. W., TAXUS-IV Investigators, (2005). Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. J Am Coll Cardiol 45: 1186-1192 [Abstract] [Full Text]  
• Vural, K. M., Iscan, Z. H., Kunt, A., Sener, E., Tasdemir, O. (2005). Off-Pump, In Situ Internal Thoracic Artery Grafting: A Durable Treatment for Single-Vessel Coronary Artery Disease. Ann. Thorac. Surg. 79: 814-818 [Abstract] [Full Text]  
• Falk, V., Walther, T., Jacobs, S., Wolf, R. K., Mohr, F. W. (2005). Facilitated MIDCAB Using a Magnetic Coupling Device. Ann. Thorac. Surg. 79: 691-693 [Abstract] [Full Text]  
• Kondyurin, A., Romanova, V., Begishev, V., Kondyurina, I., Guenzel, R., Maitz, M. F. (2005). Crosslinked Polyurethane Coating on Vascular Stents for Enhanced X-ray Contrast. Journal of Bioactive and Compatible Polymers 20: 77-93 [Abstract]  
• Klima, U., MacVaugh, H. III, Bagaev, E., Maringka, M., Kirschner, S., Beilner, J., Haverich, A. (2004). Magnetic Vascular Port in Minimally Invasive Direct Coronary Artery Bypass Grafting. Circulation 110: II-55-II-60 [Abstract] [Full Text]  
• Committee Members, , Eagle, K. A., Guyton, R. A., Davidoff, R., Edwards, F. H., Ewy, G. A., Gardner, T. J., Hart, J. C., Herrmann, H. C., Hillis, L. D., Hutter, A. M. Jr, Lytle, B. W., Marlow, R. A., Nugent, W. C., Orszulak, T. A., Task Force Members, , Antman, E. M., Smith, S. C. Jr, Alpert, J. S., Anderson, J. L., Faxon, D. P., Fuster, V., Gibbons, R. J., Gregoratos, G., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Ornato, J. P. (2004). ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) . J Am Coll Cardiol 44: 1146-1154 [Full Text]  
• Eagle, K. A., Guyton, R. A., Davidoff, R., Edwards, F. H., Ewy, G. A., Gardner, T. J., Hart, J. C., Herrmann, H. C., Hillis, L. D., Hutter, A. M. Jr, Lytle, B. W., Marlow, R. A., Nugent, W. C., Orszulak, T. A., Antman, E. M., Smith, S. C. Jr, Alpert, J. S., Anderson, J. L., Faxon, D. P., Fuster, V., Gibbons, R. J., Gregoratos, G., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Ornato, J. P. (2004). ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110: 1168-1176 [Full Text]  
• Lichtenberg, A., Klima, U., Paeschke, H., Pichlmaier, M., Ringes-Lichtenberg, S., Walles, T., Goerler, H., Haverich, A. (2004). Impact of multivessel coronary artery disease on outcome after isolated minimally invasive bypass grafting of the left anterior descending artery. Ann. Thorac. Surg. 78: 487-491 [Abstract] [Full Text]  
• Sawhney, N., Moses, J. W., Leon, M. B., Kuntz, R. E., Popma, J. J., Bachinsky, W., Bass, T., DeMaio, S., Fry, E., Holmes, D. R. Jr, Teirstein, P. S. (2004). Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents. Circulation 110: 374-379 [Abstract] [Full Text]  
• Lichtenberg, A., Klima, U., Paeschke, H., Pichlmaier, M., Ringes-Lichtenberg, S., Walles, T., Goerler, H., Haverich, A. (2004). Impact of diabetes on outcome following isolated minimally invasive bypass grafting of the left anterior descending artery. Ann. Thorac. Surg. 78: 129-134 [Abstract] [Full Text]  
• Weigang, E., Royl, J., Dencker, A., Schoellhorn, J., van de Loo, A., Beyersdorf, F. (2004). Results after MIDCAB and OPCAB surgeries: problems and consequences of incomplete angiographic follow-up in the mid-term course. ICVTS 3: 302-308 [Abstract] [Full Text]  
• Drenth, D. J., Veeger, N. J.G.M., Grandjean, J. G., Mariani, M. A., van Boven, A. J., Boonstra, P. W. (2004). Isolated high-grade lesion of the proximal LAD: a stent or off-pump LIMA?. Eur. J. Cardiothorac. Surg. 25: 567-571 [Abstract] [Full Text]  
• Nordmann, A. J, Hengstler, P., Leimenstoll, B. M, Harr, T., Young, J., Bucher, H. C (2004). Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease: A meta-analysis of randomized controlled trials. Eur Heart J 25: 69-80 [Abstract] [Full Text]  
• Khan, N. E., De Souza, A., Mister, R., Flather, M., Clague, J., Davies, S., Collins, P., Wang, D., Sigwart, U., Pepper, J. (2004). A Randomized Comparison of Off-Pump and On-Pump Multivessel Coronary-Artery Bypass Surgery. NEJM 350: 21-28 [Abstract] [Full Text]  
• Eefting, F., Nathoe, H., van Dijk, D., Jansen, E., Lahpor, J., Stella, P., Suyker, W., Diephuis, J., Suryapranata, H., Ernst, S., Borst, C., Buskens, E., Grobbee, D., de Jaegere, P. (2003). Randomized Comparison Between Stenting and Off-Pump Bypass Surgery in Patients Referred for Angioplasty. Circulation 108: 2870-2876 [Abstract] [Full Text]  
• Ohtsuka, T., Ninomiya, M., Maemura, T., Takamoto, S. (2003). Needle-guided mini-entry in video-assisted coronary artery bypass. Eur. J. Cardiothorac. Surg. 24: 644-646 [Abstract] [Full Text]  
• Bonatti, J., Danzmayr, M., Schachner, T., Friedrich, G. (2003). Intraoperative angiography for quality control in MIDCAB and OPCAB. Eur. J. Cardiothorac. Surg. 24: 647-649 [Abstract] [Full Text]  
• Boyd, W. D., Stahl, K. D. (2003). The Janus syndrome: a perspective on a new era of computer-enhanced robotic cardiac surgery. J. Thorac. Cardiovasc. Surg. 126: 625-630 [Full Text]  
• Casula, R. P, Athanasiou, T., Cherian, A., Bacon, R., Foale, R., Darzi, A. (2003). Totally endoscopic robotically enhanced coronary artery bypass on the beating heart. JRSM 96: 400-401 [Full Text]  
• LoGerfo, F. W., Drenth, D. J., Veeger, N. J.G.M., Boonstra, P. W., D'Ancona, G., Karamanoukian, H., Dragu, R. E., Wood, W. C., Thiele, H., Mohr, F. W., Schuler, G., MacGillivray, T. E., Vlahakes, G. J. (2002). Minimally Invasive Bypass Surgery. NEJM 347: 2165-2168 [Full Text]  
• Malik, I. (2002). JournalScan. Heart 88: 551-552 [Full Text]  
• (2002). Minimally Invasive Surgery vs. Stenting of the LAD Artery. Journal Watch Cardiology 2002: 1-1 [Full Text]  
• (2002). Stenting vs. Minimally Invasive Bypass Surgery for LAD Lesions. JWatch General 2002: 3-3 [Full Text]